Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapyJennifer L. Crombie, Michael Dickinson, Rajat Bannerji et al.|Blood|2024Cited by 132
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International StudyMazyar Shadman, Anthony R. Mato, Beenish S. Manzoor et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 16